History

  • 2017

    ACIST Medical Systems Announces Approval and Launch of Next-Generation FFR System
    Read More

  • 2017

    ACIST Launches Direct Sales of its CVi Contrast Delivery System in Japan
    Read More

  • 2017

    Impact of Post-Intervention Fractional Flow Reserve Measurement on Acute PCI Outcomes Investigated in Large Independent Registry
    Read More

  • 2017

    Head-to-Head Study Validates Consistent Performance of Microcatheter FFR
    Read More

  • 2017

    ACIST Japan Launches ACIST HDi® High Definition IVUS
    Read More

  • 2017

    Enrollment Complete for ACIST-FFR Multi-Center Study
    Read More

  • 2016

    ACIST Inc., Announces ACIST Japan Inc., Will Take Over Distribution of CVi Contrast Delivery Injector in Japan
    View Press Release

  • 2016

    Junichi Osawa appointed to lead ACIST’s injector business in Japan together with valued partner DVx Inc.

  • 2015

    ACIST Japan facility opens.

  • 2007

    ACIST Japan, K.K is established.

  • 2005

    Launches the ACIST CVI® Contrast Delivery System, combining the capabilities of the CMS and Voyager® into one integrated system.

  • 2004

    One thousand ACIST systems are being used in more than 30 countries worldwide.

  • 2002

    ACIST partners with DVx Inc. to sell ACIST products in Japan.

  • 1998

    Renamed ACIST (Automated Contrast Injection System Technology) Medical Systems to better reflect the company’s focus.

  • 1997

    Licenses five-year marketing rights to New Jersey-based Bracco Diagnostics Inc., which has a nationwide distribution network.

  • 1997

    Receives FDA clearance to market the CL100H system, the first injection system for diagnostic and interventional cardiology.

  • 1995

    Incorporates as Invasatec.

  • 1991

    Company is founded by Dr. Robert (Bob) F. Wilson, Professor of Medicine and Director of the Interventional Cardiology Program at the University of Minnesota.